Search

Displaying results 7651 - 7660 of 10000 in total
  1. Drug

    LYB017

    go.drugbank.com/drugs/DB33994
    Experimental

    LYB017 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  2. Drug

    ALN-6457

    go.drugbank.com/drugs/DB33986
    Experimental

    ALN-6457 is under investigation in clinical trial NCT07832370 (A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD)).

  3. Drug

    LYB027

    go.drugbank.com/drugs/DB33995
    Experimental

    LYB027 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  4. Drug

    SL1CC

    go.drugbank.com/drugs/DB34006
    Experimental

    SL1CC is under investigation in clinical trial NCT07841002 (CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia).

  5. Drug

    Robenacoxib

    go.drugbank.com/drugs/DB11455
    ExperimentalVet approved

    Robenacoxib is a non-steroidal anti-inflammatory drug used in veterinary medicine for the relief of pain and inflammation in cats and dogs.

  6. Drug

    Alanyl glutamine

    go.drugbank.com/drugs/DB11876
    Investigational

    Alanyl Glutamine is under investigation in clinical trial NCT00338221 (Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition).

    Synonyms: N(2)-L-Alanyl-L-glutamine
  7. Drug

    Figopitant

    go.drugbank.com/drugs/DB12122
    Investigational

    Figopitant is under investigation in clinical trial NCT02209714 (Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers).

  8. Drug

    Anetumab ravtansine

    go.drugbank.com/drugs/DB14809
    Investigational

    Anetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).

  9. Drug

    Osocimab

    go.drugbank.com/drugs/DB14818
    Investigational

    Osocimab is under investigation in clinical trial NCT03276143 (Factor XIa inhibition for the prevention of venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty).

  10. Drug

    Human interleukin-2

    go.drugbank.com/drugs/DB14865
    Investigational

    Human interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).